Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.20ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.221.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.221.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.221.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.221.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.221.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.224EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.224EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.224ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.224ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.224EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.224EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.224ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.224ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.618EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.618EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.618ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.618ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.618EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.618EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.618ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.618ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AF.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.89EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.89ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.89ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used